Background: The role of pulmonary function testing (PFT) as a predictor of clinically relevant endpoints in transcatheter aortic valve replacement (TAVR) is unclear.
Objective: To determine the utility of PFT in the preoperative risk stratification of patients undergoing TAVR.
Methods: An evaluation of PFT (i.